Multiplexing fluorogenic esterase-based viability assay with luciferase assays

MethodsX. 2019 Sep 12:6:2013-2020. doi: 10.1016/j.mex.2019.09.008. eCollection 2019.

Abstract

Luciferase-based reporter assays are one of the most common cell-based screening formats for drug discovery, and simultaneous evaluation of the cytotoxic effect of test compounds is of great value in reducing false-positives. Here we share a multiplex assay protocol that allows sequential measurement of cell viability (cell number) and luciferase activity of the same sample in a multi-well-plate format. The viability assay employs a fluorogenic esterase substrate, CytoRed. •This protocol allows sequential measurement of endogenous esterase activity (as a surrogate for cell number) and then luciferase activity in a single sample.•The protocol eliminates the need for parallel viability assay or protein assay using separate aliquots of the lysate.•This protocol is especially useful for assays with cells stably expressing a luciferase construct, for which co-transfection of another reporter gene is not a viable option.

Keywords: CytoRed; CytoRed-luciferase multiplex assay; Esterase; Fluorogenic substrate; Luciferase; Multiplex assay; Viability.